Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma

Acta Oncol. 2018 Aug;57(8):1131-1133. doi: 10.1080/0284186X.2018.1449251. Epub 2018 Mar 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Father-Child Relations
  • Fathers
  • Female
  • Fertility / drug effects*
  • Humans
  • Imidazoles / administration & dosage*
  • Imidazoles / adverse effects
  • Infant, Newborn
  • Male
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / pathology
  • Mutation
  • Neoplasm Metastasis
  • Oximes / administration & dosage*
  • Oximes / adverse effects
  • Pregnancy
  • Proto-Oncogene Proteins B-raf / genetics
  • Pyridones / administration & dosage*
  • Pyridones / adverse effects
  • Pyrimidinones / administration & dosage*
  • Pyrimidinones / adverse effects
  • Semen Analysis
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology

Substances

  • Imidazoles
  • Oximes
  • Pyridones
  • Pyrimidinones
  • trametinib
  • Proto-Oncogene Proteins B-raf
  • dabrafenib